AlphaBiomics

AlphaBiomics is a precision medicine company developing diagnostics that analyse the gut microbiome to guide treatment decisions. Its lead test uses a stool sample collected at home and machine learning analysis of microbial sequencing data to predict which patients with inflammatory bowel disease are likely to respond to specific biologic therapies. The company aims to help clinicians match patients to effective treatments sooner, and has also developed consumer gut health testing.